Skip to main content

MoneyWorks4Me

The company witnessed a 15.58% growth in the revenue at Rs. 1008.31 millions for the quarter ended September 2026 as compared to Rs. 872.41 millions during the year-ago period.The Total Profit for the quarter ended September 2026 of Rs. 28.80 millions grew from Rs.-33.02 millionsOperating profit for the quarter ended September 2026 rose to 80.13 millions as compared to 3.97 millions of corresponding quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 1008.31 872.41 15.58 2021.67 1578.07 28.11 3335.98 3457.68 -3.52
Other Income -36.41 -21.44 69.82 243.21 198.92 22.27 74.53 295.81 -74.80
PBIDT 80.13 3.97 1918.39 466.10 117.79 295.70 129.19 326.07 -60.38
Interest 4.00 7.51 -46.74 9.16 13.06 -29.86 26.32 4.10 541.95
PBDT 76.13 -3.54 -2250.56 456.94 104.73 336.30 102.87 321.97 -68.05
Depreciation 25.24 22.28 13.29 48.10 46.17 4.18 97.63 69.69 40.09
PBT 50.89 -25.82 -297.10 408.84 58.56 598.16 5.24 252.28 -97.92
TAX 22.09 7.20 206.81 60.05 12.21 391.81 20.20 80.27 -74.83
Deferred Tax -7.15 7.20 -199.31 18.83 12.21 54.22 -12.75 21.03 -160.63
PAT 28.80 -33.02 -187.22 348.79 46.35 652.51 -14.96 172.01 -108.70
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 7.95 0.46 1646.21 23.06 7.46 208.88 3.87 9.43 -58.93
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..